Skip to main content
Log in

Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rebound insomnia was studied in subjects, aged 25–50 years, with insomnia complaints and normal sleep, insomnia complaints and disturbed sleep, and normal sleep with no complaints (N=21,n=7 per group). Standard sleep recordings were collected on a baseline night and after abrupt discontinuation of 6 nights of 0.50 mg triazolam, tapered discontinuation (3 nights of 0.50 mg, 2 nights of 0.25 mg, and 1 night of 0.125 mg triazolam) and 6 nights of placebo. Significantly disturbed sleep on the discontinuation night compared to the baseline night was found. The relative degree of rebound insomnia was greater in the abrupt condition than in either the tapered or placebo conditions. The tapered condition reduced sleep time by half that of the abrupt condition which was twice the reduction found in the placebo condition. An overall (regardless of group or condition) difference in baseline versus discontinuation sleep was found, suggesting that pill discontinuation itself leads to sleep disturbance. Subjects did not differ in rebound insomnia as a function of pre-existing sleep disturbance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bixler E, Kales A, Soldatos C, Scharf M, Kales J (1978) Effectiveness of temazepam with short-, intermediate-, and long-term use: sleep laboratory evaluation. J Clin Pharmacol 18:110–118

    PubMed  Google Scholar 

  • Clinthrone J, Cisin I, Balter M, Mellinger G, Uhlenhuth E (1986) Changes in popular attitudes and beliefs about tranquilizers. Arch Gen Psychiatry 43:527–532

    PubMed  Google Scholar 

  • Greenblatt D, Harmatz J, Zinny M, Shader R (1987) Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. New Engl J Med 12:722–728

    Google Scholar 

  • Hull J, Bond C (1986) Social and behavioral consequences of alcohol consumption and expectancy: a meta-analysis. Psychol Bull 99:347–360

    Article  PubMed  Google Scholar 

  • Kales A, Scharf M, Kales J (1978) Rebound insomnia: a new clinical syndrome. Science 201:1039–1040

    PubMed  Google Scholar 

  • Kales A, Bixler E, Soldatos C, Vela-Bueno A, Jacoby J, Kales J (1982) Quazepam and flurazepam: long-term use and extended withdrawal. Clin Pharmacol Ther 32:781–788

    PubMed  Google Scholar 

  • Kales A, Soldatos C, Bixler E, Kales J (1983) Rebound insomnia and rebound anxiety: a review. Pharmacology 26:121–137

    PubMed  Google Scholar 

  • Merlotti L, Roehrs T, Zorick F, Stepanski E, Russo L, Roth T (1991) Rebound insomnia, duration of administration and individual differences. J Clin Psychopharmacol

  • Rechtschaffen A, Kales A A manual of standardized terminology techniques and scoring system for sleep stages of human subjects. National Institutes of Health Publ. 204, Government Printing Office, Washington DC

  • Roehrs T, Zorick F, Wittig R, Roth T (1986) Dose determinants of rebound insomnia. Br J Clin Pharmacol 22:143–147

    PubMed  Google Scholar 

  • Roehrs T, Koshorek G, Merlotti L, Zorick F, Wittig R, Roth T (1990a) Dose related effects on rebound insomnia. Sleep Res 19:84

    Google Scholar 

  • Roehrs T, Vogel G, Roth T (1990b) Rebound insomnia: its determinants and significance. Am J Med 88:39S-42S

    PubMed  Google Scholar 

  • Roehrs T, Merlotti L, Zorick F, Roth T (1991) Rebound insomnia and benzodiazepine hypnotic self administration. Psychopharmacology 107: -

  • Vela-Bueno A, Oliveros J, Dobladez-Blanco B, Arrigain-Ijurra S, Soldatos C, Kales A (1983) Brotizolam: a sleep laboratory evaluation. Eur J Clin Pharmacol 25:53–56

    Article  PubMed  Google Scholar 

  • Winokur A, Rickles K (1981) Withdrawal and pseudowithdrawal from diazepam therapy. J Clin Psychiatry 42:442–444

    PubMed  Google Scholar 

  • Zorick F, Kribbs N, Roehrs T, Roth T (1984) Polysomnographic and MMPI characteristics of patients with insomnia. In: Hindmarch I, Ott H, Roth T (eds) Sleep, benzodiazepines and performance. Springer, Berlin Heidelberg New York, pp 2–10

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roehrs, T., Merlotti, L., Zorick, F. et al. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation. Psychopharmacology 108, 67–71 (1992). https://doi.org/10.1007/BF02245287

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245287

Key words

Navigation